Joseph D. Keegan, CEO/President at MOLECULAR DEVICES CORP (MDCC), sold 5,099 shares at $30.93 ($158K) on 2006-02-15, disclosed to the SEC on 2006-02-17.
Open-market sale of $158k MDCC by CEO/President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.81 | 587 | $18K | 11.5% |
| 2 | $30.91 | 300 | $9K | 5.9% |
| 3 | $30.92 | 500 | $15K | 9.8% |
| 4 | $30.93 | 1,800 | $56K | 35.3% |
| 5 | $30.94 | 615 | $19K | 12.1% |
| 6 | $30.95 | 1,100 |
| $34K |
| 21.6% |
| 7 | $30.97 | 182 | $6K | 3.6% |
| 8 | $30.97 | 15 | $465 | 0.3% |
| Total | $30.92 avg | 5,099 | $158K | 100% |
| Filing → |
| MDCC | SELL | 2006-02-22 | $1.1M | — | Filing → |
| MDCC | SELL | 2006-02-14 | $289K | — | Filing → |
| MDCC | SELL | 2006-02-14 | $155K | — | Filing → |